Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Pozycja w akcjach #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Cena akcji
$1.34
Ostatnia synchronizacja: 2024-02-14
Kapitalizacja rynkowa
$48.96M
Zmiana (1 dzień)
-12.94%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel Promore Pharma AB (publ) (PROMO)

Kategoria

Historia ceny akcji dla Promore Pharma AB (publ) (PROMO)
Najwyższa cena zamknięcia: $2.11 dnia 2024-02-01

Najniższa cena zamknięcia: $179.71 dnia 2017-07-01
Historia cen akcji firmy Promore Pharma AB (publ) od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US